What class of drug is Tenofovir Alafenamide?
Tenofovir alafenamide is an antiviral drug that is used
in the treatment of hepatitis B infection. Hepatitis is a viral infection where
there is inflammation of the liver. Tenofovir alafenamide is a nucleoside
reverse transcriptase which functions by causing chain termination. As a
result, it inhibits the viral replication. Tenofovir alafenamide is given as an
oral tablet every day with or without a meal.
Some of the precautions one should keep in mind
while using Tenofovir alafenamide are –
K Tenofovir
Alafenamide Tablets can cause an
allergic reaction in some of the patients. Therefore it is advisable to read
complete information about medication before starting the use. Also, consult
the doctor if you experience any of the symptoms of an allergy. Redness,
rashes, swelling, and itching are some of the common signs of an allergic
reaction.
K Tenofovir alafenamide can interact with other
vitamin supplements, prescriptions and non-prescription medications. Especially
inform the doctor if you are taking a non-steroidal anti-inflammatory
medication like ibuprofen and naproxen.
K Avoid taking antacids which have calcium, magnesium
and aluminium while taking Tenofovir alafenamide tablets.
K Inform the doctor about all the past ailments
especially if you have suffered from lung infection or kidney disease.
K Tenofovir alafenamide can harm the fetus hence, it
is advisable to avoid pregnancy and breastfeeding during the treatment.
Side
effects of Tenofovir alafenamide are –
L Diarrhoea,
vomiting and also nausea
L Headache
L Decreased
urination
L Shortness
of breath
L Swelling
of feet and arms
L Dark
urine
L Yellowing
of skin and eyes
L Abnormal
heart rate
L Dizziness
and fatigue
L Blue
coloration of hand and feet
L Stomach
pain
L Increased
breathing rate
Conclusion
Tenofovir alafenamide is an effective antiviral drug
used for the treatment of hepatitis B. Although the price of Tenofovir
Alafenamide Tablets 25 mg is high, it can be purchased from Magicine Pharma at an affordable rate.
Comments